Related Experiment Videos
The metabolic topography of normal aging
J R Moeller1, T Ishikawa, V Dhawan
1Department of Psychiatry, New York State Psychiatric Institute, Columbia College of Physicians and Surgeons, New York, USA.
Summary
Normal aging involves neural system degeneration. [18F] fluorodeoxyglucose (FDG)/positron emission tomography (PET) revealed distinct metabolic patterns linked to aging, suggesting it as a potential marker.
Area of Science:
- Neuroscience
- Radiology
- Gerontology
Background:
- Normal aging is characterized by the degeneration of specific neural systems.
- Understanding the metabolic changes associated with aging is crucial for identifying biomarkers.
Purpose of the Study:
- To explore the metabolic topography of normal aging using [18F] fluorodeoxyglucose (FDG)/positron emission tomography (PET).
- To identify age-related metabolic profiles and assess their validity as aging markers.
Main Methods:
- Utilized FDG/PET to measure global and regional glucose metabolic rates (GMR and rCMRglc) in two independent groups of normal subjects.
- Applied the Scaled Subprofile Model (SSM) to regional metabolic data to identify age-related topographic profiles.
- Correlated subject scores for identified profiles with chronological age in normal populations and compared with Parkinson's disease patients.
Main Results:
- Two significant age-related topographic profiles were identified: one with relative frontal hypometabolism and another with relative basal ganglia hypermetabolism.
- Both profiles showed significant correlations with chronological age in normal subjects.
- A shared metabolic topography was observed between normal aging and Parkinson's disease, particularly involving the basal ganglia.
Conclusions:
- Healthy aging is associated with reproducible metabolic covariation profiles in specific neural systems.
- FDG/PET imaging can serve as a valuable metabolic marker for the normal aging process.
- Metabolic changes in aging may share similarities with neurodegenerative conditions like Parkinson's disease.